Sep 14, 2021 / 12:45PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. Good morning. Thanks for joining us on the floor of our health care conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. Delighted to have Waters join us today. And representing the company, we have Udit Batra, President and CEO. So welcome, Udit.
Before we get into Q&A, just wanted to rattle off my safe harbor here. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please do reach out to your Morgan Stanley sales rep.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystSo with that, Udit, I mean, like we were just talking about, it's been a little over a year since you took on the CEO role at Waters. Before we dive into the weeds, can you talk to us about what your key learnings have been along the way? What has impressed you on the upside? And
Trustpilot
